Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis: Geo Neul Park, Kyung Ho Lee, Ji Eun Moon et al.; Received March 28, 2023 Accepted September 5, 2023 Published online January 23, 2024; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis: Byung Chul Yu, Min Sung Lee, Jong Joo Moon et al.; Kidney Res Clin Pract. 2018;37(3):257-265. Published online September 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.3.257
Web of Science 4 Cited By 4; Full text PubReader PDF Supplementary Material

Clinical utility of far-infrared therapy for improvement of vascular access blood flow and pain control in hemodialysis patients: Soo Jeong Choi, Eun Hee Cho, Hye Min Jo et al.; Kidney Res Clin Pract. 2016;35(1):35-41. Published online December 31, 2015; DOI: https://doi.org/10.1016/j.krcp.2015.12.001
Web of Science 18 Cited By 13; Full text PubReader PDF

Features of atherosclerosis in hemodialysis patients: Kyong Ah Park, Hye Min Jo, Ji Soo Han et al.; Kidney Res Clin Pract. 2013;32(4):177-182. Published online November 25, 2013; DOI: https://doi.org/10.1016/j.krcp.2013.10.002
Web of Science 8 Cited By 8; Full text PubReader PDF

Impact of initial blood flow on outcomes of vascular access in hemodialysis patients: Soo Jeong Choi, Moo Yong Park, Jin Kuk Kim, Seung Duk Hwang, Kyun Her, Yongsoon Won; Kidney Res Clin Pract. 2012;31(3):151-156. Published online June 26, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.06.008
Cited By 2; Full text PubReader PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,751	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,751	C4d Puzzle in ABO-incompatible kidney transplantation
8,175	How should we treat acute kidney injury caused by renal congestion?
12,898	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,955	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.